NewsBenzinga트위스트 바이오사이언스 주목; 베어 케이브 뉴스레터, “트위스트 바이오사이언스의 문제점” 보고서 발행 트위스트 바이오사이언스 주목; 베어 케이브 뉴스레터, “트위스트 바이오사이언스의 문제점” 보고서 발행 Benzinga 2026.11.05 15:39 (GMT+0) Open on Benzinga Other news Canaccord Genuity Maintains Buy on Belite Bio, Raises Price Target to $314 Applied Optoelectronics Stock Sinks Amid AI Outlook Fears Canaccord Genuity Maintains Buy on Enovix, Lowers Price Target to $2.5 Canaccord Genuity Maintains Buy on Intuitive Machines, Lowers Price Target to $38 'A Zelle representative said that a technical issue on its platform originated with Chase' -NBC Report Canaccord Genuity Maintains Buy on Nektar Therapeutics, Lowers Price Target to $149
'A Zelle representative said that a technical issue on its platform originated with Chase' -NBC Report